XTANDI
As listed in the register: XTANDI 40 mg, comprimé pelliculé
40 mg · comprimé pelliculé
- Prescription only
- Active substance
- Enzalutamide
- Made by
- ASTELLAS PHARMA EUROPE (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands19 matching products
- Enzalutamide Teva 40 mg 40 mg · filmomhulde tablet2 makers
- Enzalutamide 1A Pharma 40 mg 40 mg · filmomhulde tablet
- Enzalutamide Accordpharma 40 mg filmomhulde tabletten 40 mg · filmomhulde tablet
- Enzalutamide Anabiosis 40 mg filmomhulde tabletten 40 mg · filmomhulde tablet
- Enzalutamide CF 40 mg 40 mg · filmomhulde tablet
- Enzalutamide Pharmascience 40 mg 40 mg · filmomhulde tablet
- Enzalutamide Pharmazac 40 mg 40 mg · filmomhulde tablet
- Enzalutamide Sandoz 40 mg 40 mg · filmomhulde tablet
Details
| Made by | ASTELLAS PHARMA EUROPE (PAYS-BAS) |
|---|---|
| Active substance | Enzalutamide |
| Strength | 40 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription initiale hospitalière annuelle · liste I · renouvellement non restreint · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/13/846 |
| Name in the register | XTANDI 40 mg, comprimé pelliculé |
| Packs | 4 plaquette(s) PVC polychlortrifluoroéthylène aluminium de 28 comprimé(s) |
| CIS | 64093355 |
| CIP13 | 3400930117644 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).